황반하출혈에서 유리체강내 조직플라스미노겐 활성체 및 SF6 가스충전술, 유리체절제술의 치료효과

• 영문명: Vitrectomy-Assisted Intravitreal Tissue Plasminogen Activator and SF6 Gas Injection on Submacular Hemorrhage
• 발행기관: 대한안과학회
• 저자명: 김민욱 임지원,Min Uk Kim, MD, Ji Won Lim, MD
• 간행물 정보: 『대한안과학회지』Ophthalmological Society,volume51,number11, 1459~1463쪽, 전체 5쪽
• 주제분류: 의약학 > 기타의약학
• 파일형태: PDF
• 발행일자: 2010.11.15

영문 초록

Purpose: To evaluate the results of vitrectomy-assisted intravitreal tissue plasminogen activator (tPA) and SF6 gas injection in the treatment of submacular hemorrhage. Methods: Thirty-one eyes of 30 consecutive patients with submacular hemorrhages undergoing vitrectomy with intravitreal tPA (50 μg/0.1 ml) and SF6 gas injection and completed 12 months of follow-up were evaluated. Results: The mean duration of visual symptoms was 4.1 days. Submacular blood was completely displaced in all 31 eyes after surgery. The best corrected visual acuity (logMAR) improved to 0.56 ± 0.46 at 12 months from 1.15 ± 0.51 at baseline (P = 0.002). The most important factors related to visual acuity at the 12-month follow-up were the underlying etiology for the submacular hemorrhage and visual acuity 3 months after surgery (P = 0.003 and P = 0.000, respectively). The 12-month visual acuity was independent of age, gender, presence of vitreous hemorrhage, sub-ILM hemorrhage, baseline visual acuity, duration of symptoms, and the diameter of the submacular hemorrhage. No retinal detachment or re-submacular hemorrhage developed during the follow-up period. Conclusions: This surgical technique can effectively displace submacular hemorrhage without complications. The 3-month visual acuity appears to predict the 12-month visual acuity. The final visual acuity was associated with the primary etiology for the submacular hemorrhage. J Korean Ophthalmol Soc 2010;51(11):1459-1463

키워드

Submacular hemorrhage, Tissue plasminogen activator, Vitrectomy